1
|
Obszynski J, Loidon H, Blanc A, Weibel JM, Pale P. Targeted modifications of neomycin and paromomycin: Towards resistance-free antibiotics? Bioorg Chem 2022; 126:105824. [DOI: 10.1016/j.bioorg.2022.105824] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Revised: 04/10/2022] [Accepted: 04/19/2022] [Indexed: 12/01/2022]
|
2
|
Subedi YP, Roberts P, Grilley M, Takemoto JY, Chang CWT. Development of Fungal Selective Amphiphilic Kanamycin: Cost-Effective Synthesis and Use of Fluorescent Analogs for Mode of Action Investigation. ACS Infect Dis 2019; 5:473-483. [PMID: 30674192 DOI: 10.1021/acsinfecdis.8b00327] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Amphiphilic aminoglycosides have attracted interest due to their novel antifungal activities. A crucial but often neglected factor for drug development in academia is cost of production. Herein is reported a one-step, inexpensive synthesis of amphiphilic alkyl kanamycins constituted with only natural components. The synthetic methodology also enabled the preparation of a series fluorescent amphiphilic aryl kanamycins for direct structure-activity mode of action studies. The lead compounds showed prominent antifungal activities against a panel of fungi, including Fusarium graminearum, Cryptococcus neoformans, and several Candida sp., and also significant antibacterial activities. With fluorescence-based whole cell assays, the aryl amphiphilic kanamycins were observed to permeabilize fungal surface membranes at faster rates than bacterial surface membranes. Also, the antifungal action of the amphiphilic kanamycins was observed to occur in a biphasic mode with an initial fast phase correlated with rapid membrane permeabilization at subminimal inhibitory concentrations and a slower phase membrane permeabilization that elevates the reactive oxygen species production leading to cell death. Inactive hydrophobic amphiphilic kanamycins displayed no membrane permeabilization. The results offer cost-effective methods for producing amphiphilic kanamycins and reveal insights into how nonfungal specific amphiphilic kanamycins can be employed for fungal specific diagnostic and therapeutic applications.
Collapse
Affiliation(s)
- Yagya Prasad Subedi
- Department of Chemistry and Biochemistry, Utah State University, 0300 Old Main Hill, Logan, Utah 84322-0300, United States
| | - Paul Roberts
- Department of Chemistry and Biochemistry, Utah State University, 0300 Old Main Hill, Logan, Utah 84322-0300, United States
| | - Michelle Grilley
- Department of Biology, Utah State University, 5305 Old Main Hill, Logan, Utah 84322-5305, United States
| | - Jon Y. Takemoto
- Department of Biology, Utah State University, 5305 Old Main Hill, Logan, Utah 84322-5305, United States
| | - Cheng-Wei Tom Chang
- Department of Chemistry and Biochemistry, Utah State University, 0300 Old Main Hill, Logan, Utah 84322-0300, United States
| |
Collapse
|
3
|
Frohlich KM, Weintraub SF, Bell JT, Todd GC, Väre VYP, Schneider R, Kloos ZA, Tabe ES, Cantara WA, Stark CJ, Onwuanaibe UJ, Duffy BC, Basanta-Sanchez M, Kitchen DB, McDonough KA, Agris PF. Discovery of Small-Molecule Antibiotics against a Unique tRNA-Mediated Regulation of Transcription in Gram-Positive Bacteria. ChemMedChem 2019; 14:758-769. [PMID: 30707489 DOI: 10.1002/cmdc.201800744] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2018] [Revised: 01/24/2019] [Indexed: 01/24/2023]
Abstract
The emergence of multidrug-resistant bacteria necessitates the identification of unique targets of intervention and compounds that inhibit their function. Gram-positive bacteria use a well-conserved tRNA-responsive transcriptional regulatory element in mRNAs, known as the T-box, to regulate the transcription of multiple operons that control amino acid metabolism. T-box regulatory elements are found only in the 5'-untranslated region (UTR) of mRNAs of Gram-positive bacteria, not Gram-negative bacteria or the human host. Using the structure of the 5'UTR sequence of the Bacillus subtilis tyrosyl-tRNA synthetase mRNA T-box as a model, in silico docking of 305 000 small compounds initially yielded 700 as potential binders that could inhibit the binding of the tRNA ligand. A single family of compounds inhibited the growth of Gram-positive bacteria, but not Gram-negative bacteria, including drug-resistant clinical isolates at minimum inhibitory concentrations (MIC 16-64 μg mL-1 ). Resistance developed at an extremely low mutational frequency (1.21×10-10 ). At 4 μg mL-1 , the parent compound PKZ18 significantly inhibited in vivo transcription of glycyl-tRNA synthetase mRNA. PKZ18 also inhibited in vivo translation of the S. aureus threonyl-tRNA synthetase protein. PKZ18 bound to the Specifier Loop in vitro (Kd ≈24 μm). Its core chemistry necessary for antibacterial activity has been identified. These findings support the T-box regulatory mechanism as a new target for antibiotic discovery that may impede the emergence of resistance.
Collapse
Affiliation(s)
- Kyla M Frohlich
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.,Current address: Regeneron Inc., Rensselaer, NY, USA
| | - Spencer F Weintraub
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.,Current address: New York Medical College, Valhalla, NY, USA
| | - Janeen T Bell
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.,Current address: Albany Medical College, Center for Physician Assistant Studies, Albany, NY, USA
| | - Gabrielle C Todd
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA
| | - Ville Y P Väre
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA
| | - Ryan Schneider
- Department of Biomedical Sciences, School of Public Health, University at Albany - State University of New York, P.O. Box 22002, Albany, NY, 12201, USA
| | - Zachary A Kloos
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.,Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, P.O. Box 22002, Albany, NY, 12201-2002, USA.,Current address: Molecular, Cellular and Developmental Biology, Yale University, West Haven, CT, USA
| | - Ebot S Tabe
- Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, P.O. Box 22002, Albany, NY, 12201-2002, USA.,Current address: Albany College of Pharmacy and Health Sciences, Albany, NY, USA
| | - William A Cantara
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.,Current address: Chemistry and Biochemistry, Ohio State University, Columbus, OH, USA
| | - Caren J Stark
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA
| | - Urenna J Onwuanaibe
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA
| | - Bryan C Duffy
- Albany Molecular Research Incorporated, 26 Corporate Circle, Albany, NY, 12203, USA.,Current address: New York State Department of Health, Albany, NY, USA
| | - Maria Basanta-Sanchez
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.,Current address: Waters Corporation, Pleasanton, CA, USA
| | - Douglas B Kitchen
- Albany Molecular Research Incorporated, 26 Corporate Circle, Albany, NY, 12203, USA
| | - Kathleen A McDonough
- Department of Biomedical Sciences, School of Public Health, University at Albany - State University of New York, P.O. Box 22002, Albany, NY, 12201, USA.,Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, P.O. Box 22002, Albany, NY, 12201-2002, USA
| | - Paul F Agris
- The RNA Institute and the Department of Biological Sciences, University at Albany - State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.,Current address: Duke University, Medical School, Durham, NC, USA
| |
Collapse
|
4
|
Kanazawa H, Saavedra OM, Maianti JP, Young SA, Izquierdo L, Smith TK, Hanessian S, Kondo J. Structure-Based Design of a Eukaryote-Selective Antiprotozoal Fluorinated Aminoglycoside. ChemMedChem 2018; 13:1541-1548. [PMID: 29766661 DOI: 10.1002/cmdc.201800166] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2018] [Revised: 05/15/2018] [Indexed: 11/12/2022]
Abstract
Aminoglycosides (AG) are antibiotics that lower the accuracy of protein synthesis by targeting a highly conserved RNA helix of the ribosomal A-site. The discovery of AGs that selectively target the eukaryotic ribosome, but lack activity in prokaryotes, are promising as antiprotozoals for the treatment of neglected tropical diseases, and as therapies to read-through point-mutation genetic diseases. However, a single nucleobase change A1408G in the eukaryotic A-site leads to negligible affinity for most AGs. Herein we report the synthesis of 6'-fluorosisomicin, the first 6'-fluorinated aminoglycoside, which specifically interacts with the protozoal cytoplasmic rRNA A-site, but not the bacterial A-site, as evidenced by X-ray co-crystal structures. The respective dispositions of 6'-fluorosisomicin within the bacterial and protozoal A-sites reveal that the fluorine atom acts only as a hydrogen-bond acceptor to favorably interact with G1408 of the protozoal A-site. Unlike aminoglycosides containing a 6'-ammonium group, 6'-fluorosisomicin cannot participate in the hydrogen-bonding pattern that characterizes stable pseudo-base-pairs with A1408 of the bacterial A-sites. Based on these structural observations it may be possible to shift the biological activity of aminoglycosides to act preferentially as antiprotozoal agents. These findings expand the repertoire of small molecules targeting the eukaryotic ribosome and demonstrate the usefulness of fluorine as a design element.
Collapse
Affiliation(s)
- Hiroki Kanazawa
- Graduate School of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554, Tokyo, Japan
| | - Oscar M Saavedra
- Department of Chemistry, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Québec, H3C 3J7, Canada
| | - Juan Pablo Maianti
- Department of Chemistry, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Québec, H3C 3J7, Canada
| | - Simon A Young
- Biomedical Sciences Research Complex, University of St. Andrews, St. Andrews, Fife, Scotland, KY16 9ST, UK
| | - Luis Izquierdo
- ISGlobal, Hospital-Clinic-Universitat de Barcelona, Barcelona, Spain
| | - Terry K Smith
- Biomedical Sciences Research Complex, University of St. Andrews, St. Andrews, Fife, Scotland, KY16 9ST, UK
| | - Stephen Hanessian
- Department of Chemistry, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Québec, H3C 3J7, Canada
| | - Jiro Kondo
- Graduate School of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554, Tokyo, Japan.,Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554, Tokyo, Japan
| |
Collapse
|
5
|
Takemoto JY, Wegulo SN, Yuen GY, Stevens JA, Jochum CC, Chang CWT, Kawasaki Y, Miller GW. Suppression of wheat Fusarium head blight by novel amphiphilic aminoglycoside fungicide K20. Fungal Biol 2018; 122:465-470. [DOI: 10.1016/j.funbio.2017.12.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2017] [Revised: 12/01/2017] [Accepted: 12/02/2017] [Indexed: 11/25/2022]
|
6
|
Kanazawa H, Baba F, Koganei M, Kondo J. A structural basis for the antibiotic resistance conferred by an N1-methylation of A1408 in 16S rRNA. Nucleic Acids Res 2017; 45:12529-12535. [PMID: 29036479 PMCID: PMC5716097 DOI: 10.1093/nar/gkx882] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2017] [Accepted: 09/23/2017] [Indexed: 12/18/2022] Open
Abstract
The aminoglycoside resistance conferred by an N1-methylation of A1408 in 16S rRNA by a novel plasmid-mediated methyltransferase NpmA can be a future health threat. In the present study, we have determined crystal structures of the bacterial ribosomal decoding A site with an A1408m1A antibiotic-resistance mutation both in the presence and absence of aminoglycosides. G418 and paromomycin both possessing a 6′-OH group specifically bind to the mutant A site and disturb its function as a molecular switch in the decoding process. On the other hand, binding of gentamicin with a 6′-NH3+ group to the mutant A site could not be observed in the present crystal structure. These observations agree with the minimum inhibitory concentration of aminoglycosides against Escherichia coli. In addition, one of our crystal structures suggests a possible conformational change of A1408 during the N1-methylation reaction by NpmA. The structural information obtained explains how bacteria acquire resistance against aminoglycosides along with a minimum of fitness cost by the N1-methylation of A1408 and provides novel information for designing the next-generation aminoglycoside.
Collapse
Affiliation(s)
- Hiroki Kanazawa
- Graduate School of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554 Tokyo, Japan
| | - Fumika Baba
- Graduate School of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554 Tokyo, Japan
| | - Mai Koganei
- Graduate School of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554 Tokyo, Japan
| | - Jiro Kondo
- Graduate School of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554 Tokyo, Japan.,Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554 Tokyo, Japan
| |
Collapse
|
7
|
Zimmermann L, Das I, Désiré J, Sautrey G, Barros R. S. V, El Khoury M, Mingeot-Leclercq MP, Décout JL. New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues. J Med Chem 2016; 59:9350-9369. [DOI: 10.1021/acs.jmedchem.6b00818] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Affiliation(s)
- Louis Zimmermann
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Indrajit Das
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Jérôme Désiré
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Guillaume Sautrey
- Unité
de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research
Institute, Université Catholique de Louvain, Avenue E.
Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Vinicius Barros R. S.
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Micheline El Khoury
- Unité
de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research
Institute, Université Catholique de Louvain, Avenue E.
Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Marie-Paule Mingeot-Leclercq
- Unité
de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research
Institute, Université Catholique de Louvain, Avenue E.
Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Jean-Luc Décout
- Département
de Pharmacochimie Moléculaire, ICMG FR 2607, University Grenoble Alpes/CNRS, UMR 5063, 470 Rue de la Chimie, BP 53, F-38041 Grenoble, France
| |
Collapse
|
8
|
Kondo J. Crystallographic Studies of the Ribosomal A-Site Molecular Switches by Using Model RNA Oligomers. Methods Mol Biol 2016; 1320:315-327. [PMID: 26227052 DOI: 10.1007/978-1-4939-2763-0_20] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
An RNA molecular switch in the aminoacyl-tRNA decoding site (A site) of the ribosome plays a key role in the decoding process of the protein biosynthesis. The switch discriminates a single cognate-tRNA from near-cognate tRNAs by changing its conformation from "off" to "on" states and recognizing the first two base pairs of codon-anticodon mini-helix to check whether these base pairs are of the canonical Watson-Crick type or not. Aminoglycoside antibiotics specifically target the "on" state of the bacterial A-site molecular switch and disturb the fidelity of the decoding process, resulting to cell death. If it occurs in human who was given aminoglycosides, it can lead to undesirable side effects. In order to understand the molecular bases of the decoding and the antibacterial and toxic side effects of aminoglycosides, it is necessary to determine the three-dimensional structures of the A-site molecular switches both in the presence and absence of aminoglycosides. This chapter focuses on methods in crystallographic studies of the A-site switches by using model RNA oligomers. The methods can be utilized in crystallographic studies of any DNA/RNA oligomers.
Collapse
Affiliation(s)
- Jiro Kondo
- Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554, Tokyo, Japan,
| |
Collapse
|
9
|
Maianti JP, Hanessian S. Structural hybridization of three aminoglycoside antibiotics yields a potent broad-spectrum bactericide that eludes bacterial resistance enzymes. MEDCHEMCOMM 2016. [DOI: 10.1039/c5md00429b] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Systematically blending structural features from obsolete aminoglycosides gleaned from X-ray co-crystal models rendered a promising antibiotic inert to enzymatic modification.
Collapse
|
10
|
Mingeot-Leclercq MP, Décout JL. Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside antibiotics and emergence of amphiphilic aminoglycosides. MEDCHEMCOMM 2016. [DOI: 10.1039/c5md00503e] [Citation(s) in RCA: 97] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Membrane anionic lipids as attractive targets in the design of amphiphilic antibacterial drugs active against resistant bacteria: molecular foundations and examples.
Collapse
Affiliation(s)
- Marie-Paule Mingeot-Leclercq
- Louvain Drug Research Institute
- Université catholique de Louvain
- Unité de Pharmacologie Cellulaire et Moléculaire
- Brussels
- Belgium
| | - Jean-Luc Décout
- Département de Pharmacochimie Moléculaire
- Université Grenoble Alpes/CNRS
- UMR 5063
- ICMG FR 2607
- F-38041 Grenoble
| |
Collapse
|
11
|
Emerging resistance to aminoglycosides in lactic acid bacteria of food origin—an impending menace. Appl Microbiol Biotechnol 2015; 100:1137-1151. [DOI: 10.1007/s00253-015-7184-y] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2015] [Revised: 11/17/2015] [Accepted: 11/19/2015] [Indexed: 02/06/2023]
|
12
|
Fosso MY, Shrestha SK, Green KD, Garneau-Tsodikova S. Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles. J Med Chem 2015; 58:9124-32. [PMID: 26592740 DOI: 10.1021/acs.jmedchem.5b01375] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Cationic amphiphiles derived from aminoglycosides (AGs) have been shown to exhibit enhanced antimicrobial activity. Through the attachment of hydrophobic residues such as linear alkyl chains on the AG backbone, interesting antibacterial and antifungal agents with a novel mechanism of action have been developed. Herein, we report the design and synthesis of seven kanamycin B (KANB) derivatives. Their antibacterial and antifungal activities, along with resistance/enzymatic, hemolytic, and cytotoxicity assays were also studied. Two of these compounds, with a C12 and C14 aliphatic chain attached at the 6″-position of KANB through a thioether linkage, exhibited good antibacterial and antifungal activity, were poorer substrates than KANB for several AG-modifying enzymes, and could delay the development of resistance in bacteria and fungi. Also, they were both relatively less hemolytic than the known membrane targeting antibiotic gramicidin and the known antifungal agent amphotericin B and were not toxic at their antifungal MIC values. Their oxidation to sulfones was also demonstrated to have no effect on their activities. Moreover, they both acted synergistically with posaconazole, an azole currently used in the treatment of human fungal infections.
Collapse
Affiliation(s)
- Marina Y Fosso
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky , 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States
| | - Sanjib K Shrestha
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky , 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States
| | - Keith D Green
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky , 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States
| | - Sylvie Garneau-Tsodikova
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky , 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States
| |
Collapse
|
13
|
Chandrika NT, Garneau-Tsodikova S. A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides. MEDCHEMCOMM 2015; 7:50-68. [PMID: 27019689 PMCID: PMC4806794 DOI: 10.1039/c5md00453e] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Since the discovery of the first aminoglycoside (AG), streptomycin, in 1943, these broad-spectrum antibiotics have been extensively used for the treatment of Gram-negative and Gram-positive bacterial infections. The inherent toxicity (ototoxicity and nephrotoxicity) associated with their long-term use as well as the emergence of resistant bacterial strains have limited their usage. Structural modifications of AGs by AG-modifying enzymes, reduced target affinity caused by ribosomal modification, and decrease in their cellular concentration by efflux pumps have resulted in resistance towards AGs. However, the last decade has seen a renewed interest among the scientific community for AGs as exemplified by the recent influx of scientific articles and patents on their therapeutic use. In this review, we use a non-conventional approach to put forth this renaissance on AG development/application by summarizing all patents filed on AGs from 2011-2015 and highlighting some related publications on the most recent work done on AGs to overcome resistance and improving their therapeutic use while reducing ototoxicity and nephrotoxicity. We also present work towards developing amphiphilic AGs for use as fungicides as well as that towards repurposing existing AGs for potential newer applications.
Collapse
Affiliation(s)
- Nishad Thamban Chandrika
- University of Kentucky, Department of Pharmaceutical Sciences, 789 South Limestone Street, Lexington, KY, USA. Fax: 859-257-7585; Tel: 859-218-1686
| | - Sylvie Garneau-Tsodikova
- University of Kentucky, Department of Pharmaceutical Sciences, 789 South Limestone Street, Lexington, KY, USA. Fax: 859-257-7585; Tel: 859-218-1686
| |
Collapse
|
14
|
Gorityala BK, Guchhait G, Schweizer F. Amphiphilic Aminoglycoside Antimicrobials in Antibacterial Discovery. CARBOHYDRATES IN DRUG DESIGN AND DISCOVERY 2015. [DOI: 10.1039/9781849739993-00255] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Amphiphilic aminoglycoside antimicrobials (AAAs) are an emerging class of polycationic antibacterial agents with broad-spectrum antibacterial activity. In contrast to aminoglycosides, which interfere with protein synthesis by interacting with the 30S ribosomal subunit, AAAs appear to target the bacterial cell wall by interactions with extracellular lipids or proteins or by enhancing the permeability of the bacterial cell wall. The physicochemical similarities between amphiphilic aminoglycosides and antimicrobial peptides, another class of polycationic amphiphiles with broad-spectrum antibacterial activity, suggest similar mode(s) of action. However, in contrast to antimicrobial peptides, AAAs are not composed of peptide bonds and as such promise to display superior metabolic stability. As a result, AAAs may be considered to be a novel class of antimicrobial peptidomimetics. Many AAAs possess impressive potent antibacterial activity against Gram-positive and Gram-negative bacteria, especially against bacterial strains that are resistant to clinically used antibiotics. In summary, AAAs promise to provide a new and rich source of antibacterial lead structures to combat antibiotic-resistant and multidrug-resistant pathogens.
Collapse
Affiliation(s)
| | - Goutam Guchhait
- Department of Chemistry, University of Manitoba Winnipeg, MB R3T 2N2 Canada
| | - Frank Schweizer
- Department of Chemistry, University of Manitoba Winnipeg, MB R3T 2N2 Canada
| |
Collapse
|
15
|
Maianti JP, Kanazawa H, Dozzo P, Matias RD, Feeney LA, Armstrong ES, Hildebrandt DJ, Kane TR, Gliedt MJ, Goldblum AA, Linsell MS, Aggen JB, Kondo J, Hanessian S. Toxicity modulation, resistance enzyme evasion, and A-site X-ray structure of broad-spectrum antibacterial neomycin analogs. ACS Chem Biol 2014; 9:2067-73. [PMID: 25019242 DOI: 10.1021/cb5003416] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Aminoglycoside antibiotics are pseudosaccharides decorated with ammonium groups that are critical for their potent broad-spectrum antibacterial activity. Despite over three decades of speculation whether or not modulation of pKa is a viable strategy to curtail aminoglycoside kidney toxicity, there is a lack of methods to systematically probe amine-RNA interactions and resultant cytotoxicity trends. This study reports the first series of potent aminoglycoside antibiotics harboring fluorinated N1-hydroxyaminobutyryl acyl (HABA) appendages for which fluorine-RNA contacts are revealed through an X-ray cocrystal structure within the RNA A-site. Cytotoxicity in kidney-derived cells was significantly reduced for the derivative featuring our novel β,β-difluoro-HABA group, which masks one net charge by lowering the pKa without compromising antibacterial potency. This novel side-chain assists in evasion of aminoglycoside-modifying enzymes, and it can be easily transferred to impart these properties onto any number of novel analogs.
Collapse
Affiliation(s)
- Juan Pablo Maianti
- Department
of Chemistry, Université de Montréal, CP 6128 Succ. Centre-Ville, Montréal, Québec H3C3J7, Canada
| | - Hiroki Kanazawa
- Department
of Materials and Life Sciences, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554 Tokyo, Japan
| | - Paola Dozzo
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - Rowena D. Matias
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - Lee Ann Feeney
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - Eliana S. Armstrong
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - Darin J. Hildebrandt
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - Timothy R. Kane
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - Micah J. Gliedt
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - Adam A. Goldblum
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - Martin S. Linsell
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - James B. Aggen
- Achaogen Inc., 7000 Shoreline Court,
Suite 371, South San Francisco, California 94080, United States
| | - Jiro Kondo
- Department
of Materials and Life Sciences, Sophia University, 7-1 Kioi-cho, Chiyoda-ku, 102-8554 Tokyo, Japan
| | - Stephen Hanessian
- Department
of Chemistry, Université de Montréal, CP 6128 Succ. Centre-Ville, Montréal, Québec H3C3J7, Canada
| |
Collapse
|
16
|
Abstract
A concise asymmetric synthesis of aminocyclitols, such as diastereomeric 2-deoxystreptamine analogues and conduramine A, is described. The Pd-catalyzed asymmetric desymmetrization of meso 1,4-dibenzolate enables the synthesis of highly oxidized cyclohexane architectures. These scaffolds can potentially be used to access new aminoglycoside antibiotics and enantiomerically pure α-glucosidase inhibitors.
Collapse
Affiliation(s)
- Barry M Trost
- Department Of Chemistry, Stanford University, Stanford, CA (USA).
| | | |
Collapse
|
17
|
Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections. Future Med Chem 2014; 5:1285-309. [PMID: 23859208 DOI: 10.4155/fmc.13.80] [Citation(s) in RCA: 82] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Shortly after the discovery of the first antibiotics, bacterial resistance began to emerge. Many mechanisms give rise to resistance; the most prevalent mechanism of resistance to the aminoglycoside (AG) family of antibiotics is the action of aminoglycoside-modifying enzymes (AMEs). Since the identification of these modifying enzymes, many efforts have been put forth to prevent their damaging alterations of AGs. These diverse strategies are discussed within this review, including: creating new AGs that are unaffected by AMEs; developing inhibitors of AMEs to be co-delivered with AGs; or regulating AME expression. Modern high-throughput methods as well as drug combinations and repurposing are highlighted as recent drug-discovery efforts towards fighting the increasing antibiotic resistance crisis.
Collapse
|
18
|
Abstract
The attachment of alkyl and other hydrophobic groups to traditional antibacterial kanamycins and neomycins creates amphiphilic aminoglycosides with altered antimicrobial properties. In this review, we summarize the discovery of amphiphilic kanamycins that are antifungal, but not antibacterial, and that inhibit the growth of fungi by perturbation of plasma membrane functions. With low toxicities against plant and mammalian cells, they appear to specifically target the fungal plasma membrane. These new antifungal agents offer new options for fighting fungal pathogens and are examples of reviving old drugs to confront new therapeutic challenges.
Collapse
Affiliation(s)
- C-W T Chang
- Department of Chemistry & Biochemistry, Utah State University, Logan, Utah 84322-0300 U.S.A
| | - J Y Takemoto
- Department of Biology, Utah State University, Logan, Utah 84322-5305 U.S.A
| |
Collapse
|
19
|
Kondo J, Westhof E. Aminoglycoside Antibiotics: Structural Decoding of Inhibitors Targeting the Ribosomal Decoding A Site. Antibiotics (Basel) 2013. [DOI: 10.1002/9783527659685.ch19] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
20
|
Zimmermann L, Bussière A, Ouberai M, Baussanne I, Jolivalt C, Mingeot-Leclercq MP, Décout JL. Tuning the Antibacterial Activity of Amphiphilic Neamine Derivatives and Comparison to Paromamine Homologues. J Med Chem 2013; 56:7691-705. [DOI: 10.1021/jm401148j] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Affiliation(s)
- Louis Zimmermann
- Département
de Pharmacochimie Moléculaire, Université de Grenoble I/CNRS, UMR 5063, ICMG FR
2607, 470 rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Antoine Bussière
- Département
de Pharmacochimie Moléculaire, Université de Grenoble I/CNRS, UMR 5063, ICMG FR
2607, 470 rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Myriam Ouberai
- Unité de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Isabelle Baussanne
- Département
de Pharmacochimie Moléculaire, Université de Grenoble I/CNRS, UMR 5063, ICMG FR
2607, 470 rue de la Chimie, BP 53, F-38041 Grenoble, France
| | - Claude Jolivalt
- Ecole Nationale de Chimie de Paris/CNRS, UMR
7573, 11 rue Pierre et Marie Curie, F-75231 Paris cedex 05, France
| | - Marie-Paule Mingeot-Leclercq
- Unité de Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 73, B1.73.05, B-1200 Brussels, Belgium
| | - Jean-Luc Décout
- Département
de Pharmacochimie Moléculaire, Université de Grenoble I/CNRS, UMR 5063, ICMG FR
2607, 470 rue de la Chimie, BP 53, F-38041 Grenoble, France
| |
Collapse
|
21
|
Shi K, Caldwell SJ, Fong DH, Berghuis AM. Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance. Front Cell Infect Microbiol 2013; 3:22. [PMID: 23805415 PMCID: PMC3691515 DOI: 10.3389/fcimb.2013.00022] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2013] [Accepted: 06/04/2013] [Indexed: 01/10/2023] Open
Abstract
Aminoglycosides are a class of antibiotics with a broad spectrum of antimicrobial activity. Unfortunately, resistance in clinical isolates is pervasive, rendering many aminoglycosides ineffective. The most widely disseminated means of resistance to this class of antibiotics is inactivation of the drug by aminoglycoside-modifying enzymes (AMEs). There are two principal strategies to overcoming the effects of AMEs. The first approach involves the design of novel aminoglycosides that can evade modification. Although this strategy has yielded a number of superior aminoglycoside variants, their efficacy cannot be sustained in the long term. The second approach entails the development of molecules that interfere with the mechanism of AMEs such that the activity of aminoglycosides is preserved. Although such a molecule has yet to enter clinical development, the search for AME inhibitors has been greatly facilitated by the wealth of structural information amassed in recent years. In particular, aminoglycoside phosphotransferases or kinases (APHs) have been studied extensively and crystal structures of a number of APHs with diverse regiospecificity and substrate specificity have been elucidated. In this review, we present a comprehensive overview of the available APH structures and recent progress in APH inhibitor development, with a focus on the structure-guided strategies.
Collapse
Affiliation(s)
- Kun Shi
- Groupe de Recherche Axé sur la Structure des Protéines, Department of Biochemistry, McGill UniversityMontreal, QC, Canada
| | - Shane J. Caldwell
- Groupe de Recherche Axé sur la Structure des Protéines, Department of Biochemistry, McGill UniversityMontreal, QC, Canada
| | - Desiree H. Fong
- Groupe de Recherche Axé sur la Structure des Protéines, Department of Biochemistry, McGill UniversityMontreal, QC, Canada
| | - Albert M. Berghuis
- Groupe de Recherche Axé sur la Structure des Protéines, Department of Biochemistry, McGill UniversityMontreal, QC, Canada
- Department of Microbiology and Immunology, McGill UniversityMontreal, QC, Canada
| |
Collapse
|
22
|
Abstract
Aminoglycoside antibiotics were among the first antibiotics discovered and used clinically. Although they have never completely fallen out of favor, their importance has waned due to the emergence of other broad-spectrum antibiotics with fewer side effects. Today, with the dramatically increasing rate of infections caused by multidrug-resistant bacteria, focus has returned to aminoglycoside antibiotics as one of the few remaining treatment options, particularly for Gram-negative pathogens. Although the mechanisms of resistance are reasonably well understood, our knowledge about the mode of action of aminoglycosides is still far from comprehensive. In the face of emerging bacterial infections that are virtually untreatable, it is time to have a fresh look at this old class to reinvigorate the struggle against multidrug-resistant pathogens.
Collapse
Affiliation(s)
- Bernd Becker
- Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Road, Brisbane,
Queensland 4072, Australia
| | - Matthew A. Cooper
- Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Road, Brisbane,
Queensland 4072, Australia
| |
Collapse
|
23
|
Herzog IM, Feldman M, Eldar-Boock A, Satchi-Fainaro R, Fridman M. Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity. MEDCHEMCOMM 2013. [DOI: 10.1039/c2md20162c] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Hemolysis caused by amphiphilic tobramycin antimicrobial agents is significantly reduced by altering the bond linking their hydrophobic and hydrophilic parts.
Collapse
Affiliation(s)
- Ido M. Herzog
- School of Chemistry
- Tel Aviv University
- Tel Aviv 69978
- Israel
| | - Mark Feldman
- School of Chemistry
- Tel Aviv University
- Tel Aviv 69978
- Israel
| | - Anat Eldar-Boock
- Department of Physiology and Pharmacology
- Sackler School of Medicine
- Tel Aviv University
- Tel Aviv 69978
- Israel
| | - Ronit Satchi-Fainaro
- Department of Physiology and Pharmacology
- Sackler School of Medicine
- Tel Aviv University
- Tel Aviv 69978
- Israel
| | - Micha Fridman
- School of Chemistry
- Tel Aviv University
- Tel Aviv 69978
- Israel
| |
Collapse
|
24
|
Zhang W, Chen Y, Liang Q, Li H, Jin H, Zhang L, Meng X, Li Z. Design, Synthesis, and Antibacterial Activities of Conformationally Constrained Kanamycin A Derivatives. J Org Chem 2012; 78:400-9. [DOI: 10.1021/jo302247x] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Wenxuan Zhang
- Department of Chemical Biology and ‡Department of
Medicinal Chemistry, School of Pharmaceutical Sciences,
The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
| | - Ying Chen
- Department of Chemical Biology and ‡Department of
Medicinal Chemistry, School of Pharmaceutical Sciences,
The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
| | - Qingzhao Liang
- Department of Chemical Biology and ‡Department of
Medicinal Chemistry, School of Pharmaceutical Sciences,
The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
| | - Hui Li
- Department of Chemical Biology and ‡Department of
Medicinal Chemistry, School of Pharmaceutical Sciences,
The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
| | - Hongwei Jin
- Department of Chemical Biology and ‡Department of
Medicinal Chemistry, School of Pharmaceutical Sciences,
The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
| | - Liangren Zhang
- Department of Chemical Biology and ‡Department of
Medicinal Chemistry, School of Pharmaceutical Sciences,
The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
| | - Xiangbao Meng
- Department of Chemical Biology and ‡Department of
Medicinal Chemistry, School of Pharmaceutical Sciences,
The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
| | - Zhongjun Li
- Department of Chemical Biology and ‡Department of
Medicinal Chemistry, School of Pharmaceutical Sciences,
The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
| |
Collapse
|
25
|
Romanowska J, Reuter N, Trylska J. Comparing aminoglycoside binding sites in bacterial ribosomal RNA and aminoglycoside modifying enzymes. Proteins 2012; 81:63-80. [PMID: 22907688 DOI: 10.1002/prot.24163] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2012] [Revised: 08/02/2012] [Accepted: 08/09/2012] [Indexed: 11/10/2022]
Abstract
Aminoglycoside antibiotics are used against severe bacterial infections. They bind to the bacterial ribosomal RNA and interfere with the translation process. However, bacteria produce aminoglycoside modifying enzymes (AME) to resist aminoglycoside actions. AMEs form a variable group and yet they specifically recognize and efficiently bind aminoglycosides, which are also diverse in terms of total net charge and the number of pseudo-sugar rings. Here, we present the results of 25 molecular dynamics simulations of three AME representatives and aminoglycoside ribosomal RNA binding site, unliganded and complexed with an aminoglycoside, kanamycin A. A comparison of the aminoglycoside binding sites in these different receptors revealed that the enzymes efficiently mimic the nucleic acid environment of the ribosomal RNA binding cleft. Although internal dynamics of AMEs and their interaction patterns with aminoglycosides differ, the energetical analysis showed that the most favorable sites are virtually the same in the enzymes and RNA. The most copied interactions were of electrostatic nature, but stacking was also replicated in one AME:kanamycin complex. In addition, we found that some water-mediated interactions were very stable in the simulations of the complexes. We show that our simulations reproduce well findings from NMR or X-ray structural studies, as well as results from directed mutagenesis. The outcomes of our analyses provide new insight into aminoglycoside resistance mechanism that is related to the enzymatic modification of these drugs.
Collapse
Affiliation(s)
- Julia Romanowska
- Department of Biophysics, Faculty of Physics, University of Warsaw, Hoża 69, 00-681 Warsaw, Poland.
| | | | | |
Collapse
|
26
|
Das I, Désiré J, Manvar D, Baussanne I, Pandey VN, Décout JL. A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription. J Med Chem 2012; 55:6021-32. [PMID: 22698070 PMCID: PMC3400927 DOI: 10.1021/jm300253q] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
The 6-aminoglucosamine ring of the aminoglycoside antibiotic neomycin B (ring II) was conjugated to a 16-mer peptide nucleic acid (PNA) targeting HIV-1 TAR RNA. For this purpose, we prepared the aminoglucosamine monomer 15 and attached it to the protected PNA prior to its cleavage from the solid support. We found that the resulting PNA-aminoglucosamine conjugate is stable under acidic conditions, efficiently taken up by the human cells and fairly distributed in both cytosol and nucleus without endosomal entrapment because cotreatment with endosome-disrupting agent had no effect on its cellular distribution. The conjugate displayed very high target specificity in vitro and strongly inhibited Tat mediated transactivation of HIV-1 LTR transcription in a cell culture system. The unique properties of this new class of PNA conjugate suggest it to be a potential candidate for therapeutic application.
Collapse
Affiliation(s)
- Indrajit Das
- Université de Grenoble I/CNRS, UMR 5063, Département de Pharmacochimie Moléculaire, ICMG FR 2607, 470 rue de la Chimie BP 53 F-38041 Grenoble, France
| | - Jérôme Désiré
- Université de Grenoble I/CNRS, UMR 5063, Département de Pharmacochimie Moléculaire, ICMG FR 2607, 470 rue de la Chimie BP 53 F-38041 Grenoble, France
| | - Dinesh Manvar
- Center for the Study of Emerging and Re-emerging Pathogens, UMDNJ-New Jersey Medical School, Department of Biochemistry and Molecular Biology, 185 South Orange Avenue, Newark, New Jersey 07103, USA
| | - Isabelle Baussanne
- Université de Grenoble I/CNRS, UMR 5063, Département de Pharmacochimie Moléculaire, ICMG FR 2607, 470 rue de la Chimie BP 53 F-38041 Grenoble, France
| | - Virendra N. Pandey
- Center for the Study of Emerging and Re-emerging Pathogens, UMDNJ-New Jersey Medical School, Department of Biochemistry and Molecular Biology, 185 South Orange Avenue, Newark, New Jersey 07103, USA
| | - Jean-Luc Décout
- Université de Grenoble I/CNRS, UMR 5063, Département de Pharmacochimie Moléculaire, ICMG FR 2607, 470 rue de la Chimie BP 53 F-38041 Grenoble, France
| |
Collapse
|
27
|
Herzog IM, Green KD, Berkov-Zrihen Y, Feldman M, Vidavski RR, Eldar-Boock A, Satchi-Fainaro R, Eldar A, Garneau-Tsodikova S, Fridman M. 6''-Thioether tobramycin analogues: towards selective targeting of bacterial membranes. Angew Chem Int Ed Engl 2012; 51:5652-6. [PMID: 22499286 DOI: 10.1002/anie.201200761] [Citation(s) in RCA: 74] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2012] [Revised: 03/08/2012] [Indexed: 12/20/2022]
Affiliation(s)
- Ido M Herzog
- School of Chemistry, Tel Aviv University, Tel Aviv 66978, Israel
| | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Herzog IM, Green KD, Berkov-Zrihen Y, Feldman M, Vidavski RR, Eldar-Boock A, Satchi-Fainaro R, Eldar A, Garneau-Tsodikova S, Fridman M. 6′′-Thioether Tobramycin Analogues: Towards Selective Targeting of Bacterial Membranes. Angew Chem Int Ed Engl 2012. [DOI: 10.1002/ange.201200761] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
29
|
Findlay B, Zhanel GG, Schweizer F. Neomycin–phenolic conjugates: Polycationic amphiphiles with broad-spectrum antibacterial activity, low hemolytic activity and weak serum protein binding. Bioorg Med Chem Lett 2012; 22:1499-503. [DOI: 10.1016/j.bmcl.2012.01.025] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2011] [Revised: 01/04/2012] [Accepted: 01/09/2012] [Indexed: 01/24/2023]
|
30
|
Jackowski O, Bussière A, Vanhaverbeke C, Baussanne I, Peyrin E, Mingeot-Leclercq MP, Décout JL. Major increases of the reactivity and selectivity in aminoglycoside O-alkylation due to the presence of fluoride ions. Tetrahedron 2012. [DOI: 10.1016/j.tet.2011.10.102] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
31
|
Hanessian S, Giguère A, Grzyb J, Maianti JP, Saavedra OM, Aggen JB, Linsell MS, Goldblum AA, Hildebrandt DJ, Kane TR, Dozzo P, Gliedt MJ, Matias RD, Feeney LA, Armstrong ES. Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin Analogue. ACS Med Chem Lett 2011; 2:924-8. [PMID: 24900282 DOI: 10.1021/ml200202y] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2011] [Accepted: 09/15/2011] [Indexed: 11/28/2022] Open
Abstract
Deoxygenation of the diol groups in rings A and D of neomycin in combination with the introduction of an N1-(l)-HABA group in the 2-deoxystreptamine subunit (ring B) leads to a novel and potent antibiotic (1) with activity against strains of S. aureus carrying known aminoglycoside resistance determinants, as well as against an extended panel of Methicillin-resistant S. aureus isolates (n = 50). Antibiotic 1 displayed >64 fold improvement in MIC50 and MIC90 against this MRSA collection when compared to the clinically relevant aminoglycosides amikacin and gentamicin. The synthesis was achieved in six steps and 15% overall yield.
Collapse
Affiliation(s)
- Stephen Hanessian
- Department of Chemistry, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montréal, Quebec H3C 3J7, Canada
| | - Alexandre Giguère
- Department of Chemistry, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montréal, Quebec H3C 3J7, Canada
| | - Justyna Grzyb
- Department of Chemistry, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montréal, Quebec H3C 3J7, Canada
| | - Juan Pablo Maianti
- Department of Chemistry, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montréal, Quebec H3C 3J7, Canada
| | - Oscar M. Saavedra
- Department of Chemistry, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montréal, Quebec H3C 3J7, Canada
| | - James B. Aggen
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| | - Martin S. Linsell
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| | - Adam A. Goldblum
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| | - Darin J. Hildebrandt
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| | - Timothy R. Kane
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| | - Paola Dozzo
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| | - Micah J. Gliedt
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| | - Rowena D. Matias
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| | - Lee Ann Feeney
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| | - Eliana S. Armstrong
- Achaogen Inc., 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, United States
| |
Collapse
|
32
|
Hanessian S, Maianti JP, Matias RD, Feeney LA, Armstrong ES. Hybrid aminoglycoside antibiotics via Tsuji palladium-catalyzed allylic deoxygenation. Org Lett 2011; 13:6476-9. [PMID: 22085292 DOI: 10.1021/ol2027703] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Biosynthetically inspired manipulation of the antibiotic paromomycin led, in six high-yielding steps, to a ring A harboring an α,β-unsaturated 6'-aldehyde and an allylic 3'-methylcarbonate group. Tsuji deoxygenation in the presence of 5 mol % Pd(2)(dba)(3) and Bu(3)P granted access to a novel series of 3',4'-dideoxy-4',5'-dehydro ring A hybrids. The neomycin-sisomicin hybrid exhibited superior in vitro antibacterial activity to the parent compound neomycin.
Collapse
Affiliation(s)
- Stephen Hanessian
- Department of Chemistry, Université de Montréal, C. P. 6128, Succ. Centre-Ville, Montréal, QC, Canada, H3C 3J7.
| | | | | | | | | |
Collapse
|
33
|
Szychowski J, Kondo J, Zahr O, Auclair K, Westhof E, Hanessian S, Keillor JW. Inhibition of aminoglycoside-deactivating enzymes APH(3')-IIIa and AAC(6')-Ii by amphiphilic paromomycin O2''-ether analogues. ChemMedChem 2011; 6:1961-6. [PMID: 21905229 DOI: 10.1002/cmdc.201100346] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2011] [Indexed: 11/08/2022]
Affiliation(s)
- Janek Szychowski
- Department of Chemistry, Université de Montréal, C. P. 6128, Succ. Centre-Ville, Montréal, QC, H3C 3J7, Canada
| | | | | | | | | | | | | |
Collapse
|